Madlen Marx

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 3

Top Topics

Regulatory T Cells

Anti Inflammatory

Dendritic Cells

Top Venues

Journal of neuro-oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Sascha Marx, Fabian Wilken, Isabel Wagner, Madlen Marx, Sascha Troschke-Meurer, Maxi Zumpe, Sandra Bien-Moeller, Martin Weidemeier, Joerg Baldauf, Steffen K Fleck, Bernhard H Rauch, Henry W S Schroeder, Holger N Lode, Nikolai Siebert
GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma. Journal of neuro-oncology 147 (3) (2020)
Sascha Troschke-Meurer, Nikolai Siebert, Madlen Marx, Maxi Zumpe, Karoline Ehlert, Oliver Mutschlechner, Hans Loibner, Ruth Ladenstein, Holger N Lode
Low CD4⁺/CD25⁺/CD127⁻ regulatory T cell- and high INF-γ levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18/CHO combined with interleukin-2. Oncoimmunology 8 (12) (2019)
Madlen Marx, Maxi Zumpe, Sascha Troschke-Meurer, Diana Shah, Holger N Lode, Nikolai Siebert
Co-expression of IL-15 enhances anti-neuroblastoma effectivity of a tyrosine hydroxylase-directed DNA vaccination in mice. PloS one 13 (11) (2018)